U.S. Stock Earnings Reports & Market News
Linkhome Holdings Inc FY2025 Q3 Financial Analysis: Revenue Up 162%, Net Loss Narrower
Executive Summary In the third quarter of fiscal year 2025, Linkhome Holdings…
U.S. GoldMining Inc Q3 FY2025: Net Loss Decreased 35.0% YoY, Cash Reserves at $3.33M
Executive Summary U.S. GoldMining Inc (NASDAQ: USGO) reported its third quarter fiscal…
Falcon’s Beyond Global Inc FY2025Q3 Revenue Increased 26% YoY in U.S. Stock Market Analysis
Executive Summary Falcon’s Beyond Global Inc (FBYD) reported its fiscal third quarter…
Klotho Neurosciences Inc Q3 FY2025: Net Income Decreased by 105.4%
Executive Summary This report provides a comprehensive analysis of Klotho Neurosciences, Inc.…
NVVE 2025 Q3 Financial Analysis: Revenue Decreased 16.4%, Net Loss of $4.79M
Executive Summary In the third quarter of 2025, NVVE reported a significant…
Serve Robotics Inc FY2025Q3 Revenue Increased 29% Year-Over-Year in 2025Q3
Executive Summary Serve Robotics Inc., traded on NASDAQ under the ticker SERV,…
BioAtla Inc NASDAQ BCAB Q3 2025 Net Loss Decreased 28.4% YoY Reflecting Cost Management
Executive Summary BioAtla Inc (NASDAQ: BCAB) reported its Q3 2025 financial results,…
Society Pass Inc FY2025 Q3 Financial Report: Revenue Decreased 18.2%, Net Loss $161,770
Executive Summary In the third quarter of fiscal year 2025, Society Pass…
TMC the metals Co Inc FY2025Q3 Net Loss Increased by 184% Compared to Prior Year
Executive Summary In the third quarter of fiscal year 2025, TMC the…
Neve Yarak Inc FY2025 Q3 Financial Report: Largest Change in Net Loss 5395% Increase
Executive Summary Neve Yarak Inc, trading under the symbol NITO on NASDAQ,…
CISO Global Inc FY2025Q3 Revenue Increased 26% YoY, Stock Price Outlook
Executive Summary In the third quarter of fiscal year 2025, CISO Global…
CoreWeave Inc FY2025Q3 Revenue Increased Significantly by 45.2%
Key Metrics Metric Q3 2025 Q2 2025 Change Revenue $150 million $103…
Reviva Pharmaceuticals Holdings Inc FY2024 Q3 Financial Analysis: Net Loss Decreased 20.4%
Executive Summary Reviva Pharmaceuticals Holdings Inc (RVPH) reported its Q3 FY2024 financial…
Virgin Galactic Holdings Inc FY2025Q3 Revenue Increased 55% YoY in 2025Q3 Financial Report
Executive Summary Virgin Galactic Holdings Inc (SPCE) reported a significant increase in…
Wrap Technologies Inc FY2025Q3 Revenue Increased 157% YoY, Net Loss Narrowed Significantly
Executive Summary Wrap Technologies Inc, trading under the ticker WRAP, reported its…
Spero Therapeutics Inc FY2025Q3 Revenue Increased 26% YoY, Stock Performance Highlights
Executive Summary In the third quarter of fiscal year 2025, Spero Therapeutics…
GRAIL Inc Q3 FY2025 Revenue Increased 26% Year-Over-Year, Stock Ticker GRAL
Executive Summary GRAIL Inc, a leading healthcare innovator specializing in early cancer…
Q32 Bio Inc. FY2025Q3 Net Loss Increased by 58.4% Compared to Prior Year
Executive Summary Q32 Bio Inc., a leading clinical-stage biotechnology company focused on…
Moleculin Biotech Inc FY2025 Q3 Net Loss Increased by 49.4% Compared to Prior Year
Executive Summary In the third quarter of fiscal year 2025, Moleculin Biotech…
Iterum Therapeutics plc FY2025 Q3 Largest Change in Net Loss Decreased 11.4% YoY
Executive Summary Iterum Therapeutics plc, trading under the ticker ITRM on NASDAQ,…
Actuate Therapeutics Inc FY2025Q3 Net Loss Increased by 28.4% Compared to Prior Year
Executive Summary Actuate Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing…
ELTX Q3 FY2025: Net Loss Increased 46.4% YoY, Largest Change in Financial Metrics
Executive Summary Elicio Therapeutics, Inc. (NASDAQ: ELTX) reported its financial results for…
Contango Ore Inc. (CTGO) Q3 FY2025 Revenue Increased 26.4% YoY, Largest Change
Executive Summary Contango Ore Inc. (CTGO) reported its fiscal third quarter of…
Precigen Inc FY2025 Q3 Financial Report: Net Loss Decreased by 39.2% YoY
Executive Summary Precigen Inc (NASDAQ: PGEN) reported its third quarter of FY2025,…
TechPrecision Corporation FY2025 Q3 Financial Analysis: Revenue Slightly Decreased, Net Loss Remains High
Executive Summary TechPrecision Corporation reported its third quarter of fiscal year 2025…
Company TSS Inc FY2025Q3 Revenue Decreased 40.2% YoY, Net Loss of $1.5M
Executive Summary For the third quarter of fiscal year 2025, TSS Inc.…
Neuphoria Therapeutics Inc Q3 FY2025: Revenue Up 10,000%, Net Income $11.26M
Executive Summary Neuphoria Therapeutics Inc. reported a remarkable financial turnaround in Q3…
Marker Therapeutics Inc FY2025 Q3 Financial Analysis: Net Loss Decreased 13.1%
Executive Summary In the third quarter of fiscal year 2025, Marker Therapeutics,…
Red Cat Holdings Inc Q3 FY2025 Financial Analysis: Net Income Decreased $5.5M
Executive Summary Red Cat Holdings Inc (RCAT) reported its third quarter FY2025…
NIQ FY2025Q3 Revenue Increased 7.2% Year-Over-Year in NIQ Global Intelligence plc
Executive Summary NIQ, a leading global consumer intelligence company, reported its fiscal…